Information Concerning Endocrine Therapy and Adherence of Patients with Breast and Prostate Cancer

Clin Oncol (R Coll Radiol). 2015 Aug;27(8):482-3. doi: 10.1016/j.clon.2015.03.002. Epub 2015 Apr 11.

Authors

B Linke¹, P Liebl¹, D Marten¹, C Stoll², B Jung³, P Wuensch³, J Huebner³

Affiliations

¹ German Cancer Society, Berlin, Germany.
² Clinic Herzoghoehe, Bayreuth, Germany.
³ Working Group Integrative Oncology, Dr. Senckenberg Chronomedical Institute, J.W. Goethe University, Frankfurt, Germany.

PMID: 25869258
DOI: 10.1016/j.clon.2015.03.002

No abstract available

Publication types

Letter

MeSH terms

Aged
Antineoplastic Agents, Hormonal / adverse effects*
Antineoplastic Agents, Hormonal / therapeutic use
Breast Neoplasms / drug therapy*
Breast Neoplasms / therapy
Female
Hormone Antagonists / adverse effects*
Hormone Antagonists / therapeutic use
Humans
Male
Medication Adherence
Middle Aged
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / therapy

Substances

Antineoplastic Agents, Hormonal
Hormone Antagonists